149 related articles for article (PubMed ID: 38604798)
1. [Bone destruction was the initial symptom in myeloid/lymphoid neoplasms associated with eosinophilia and rearrangements of PDGFRα: a case report].
Guo Y; Lyu GQ; Zhang Y; Wang LH; Wu JR; Lu XL; Qin WL; Wu S
Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):195. PubMed ID: 38604798
[No Abstract] [Full Text] [Related]
2. A Novel USP25::PDGFRA Gene Fusion in a 78 Year Old Patient with a Myeloid Neoplasm.
Dalland JC; Blackburn PR; Reichard KK; Johnson SH; Smadbeck JB; Vasmatzis G; Hoppman NL; Xu X; Greipp PT; Baughn LB; Peterson JF
Lab Med; 2022 Sep; 53(5):e134-e138. PubMed ID: 35217871
[TBL] [Abstract][Full Text] [Related]
3. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
[TBL] [Abstract][Full Text] [Related]
4. [Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1].
Fan XS; Wang SA
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):779-83. PubMed ID: 23302345
[No Abstract] [Full Text] [Related]
5. Atypical Phenotype and Treatment Response Pattern in a Patient with FIP1L1-PDGFRα Mutation.
Bikhchandani M; Johnson R; Tuan B; Tefferi A
Acta Haematol; 2018; 140(2):67-70. PubMed ID: 30184522
[TBL] [Abstract][Full Text] [Related]
6. Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review.
Savage N; George TI; Gotlib J
Int J Lab Hematol; 2013 Oct; 35(5):491-500. PubMed ID: 23489324
[TBL] [Abstract][Full Text] [Related]
7. Myeloid neoplasms with eosinophilia and FIP1L1-PDGFRA fusion gene: another point of view.
Helbig G; Kyrcz-Krzemien S
Leuk Lymphoma; 2013 Apr; 54(4):897-8. PubMed ID: 23025324
[No Abstract] [Full Text] [Related]
8. A challenging diagnosis of myeloid/lymphoid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement.
Coltro G; Santi R
Blood; 2023 May; 141(20):2541. PubMed ID: 37200055
[No Abstract] [Full Text] [Related]
9. [Myeloid neoplasms with eosinophilia and FGFRl rearrangement: a case report].
Li YY; Wang C; Zhang M; Du ZH; Hu RP; Bai J; Su KJ; Liu XL; Yang Y; Tan YH; Gao SJ; Li W
Zhonghua Xue Ye Xue Za Zhi; 2022 Jan; 43(1):80. PubMed ID: 35232001
[No Abstract] [Full Text] [Related]
10. Molecular analysis of PDGFRalpha/beta genes in core binding factor leukemia with eosinophilia.
Monma F; Nishii K; Lorenzo F; Usui E; Ueda Y; Watanabe Y; Kawakami K; Oka K; Mitani H; Sekine T; Tamaki S; Mizutani M; Yagasaki F; Doki N; Miyawaki S; Katayama N; Shiku H
Eur J Haematol; 2006 Jan; 76(1):18-22. PubMed ID: 16343267
[TBL] [Abstract][Full Text] [Related]
11. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2.
Pozdnyakova O; Orazi A; Kelemen K; King R; Reichard KK; Craig FE; Quintanilla-Martinez L; Rimsza L; George TI; Horny HP; Wang SA
Am J Clin Pathol; 2021 Feb; 155(2):160-178. PubMed ID: 33367495
[TBL] [Abstract][Full Text] [Related]
12. Myeloid neoplasms with eosinophilia.
Reiter A; Gotlib J
Blood; 2017 Feb; 129(6):704-714. PubMed ID: 28028030
[TBL] [Abstract][Full Text] [Related]
13. Myeloid/lymphoid neoplasm associated with eosinophilia and concurrent rearrangement of PDGFRA and FGFR1: A very rare pediatric case.
Wang B; Wang X; Lin J; Zhang Y; Gan W; Li T
Pediatr Blood Cancer; 2023 Oct; 70(10):e30507. PubMed ID: 37336772
[No Abstract] [Full Text] [Related]
14. Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate.
Rathe M; Kristensen TK; Møller MB; Carlsen NL
Pediatr Blood Cancer; 2010 Oct; 55(4):730-2. PubMed ID: 20589620
[TBL] [Abstract][Full Text] [Related]
15. Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia.
von Bubnoff N; Sandherr M; Schlimok G; Andreesen R; Peschel C; Duyster J
Leukemia; 2005 Feb; 19(2):286-7. PubMed ID: 15618966
[No Abstract] [Full Text] [Related]
16. Myeloid neoplasm with rearrangement of PDGFRA, but with no significant eosinophilia: should we broaden the World Health Organization definition of the entity?
Rudzki Z; Giles L; Cross NC; Lumley M
Br J Haematol; 2012 Mar; 156(5):558. PubMed ID: 22224867
[No Abstract] [Full Text] [Related]
17. Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation.
Pardanani A; Lasho T; Barraco D; Patnaik M; Elala Y; Tefferi A
Am J Hematol; 2016 Mar; 91(3):E10-1. PubMed ID: 26663400
[No Abstract] [Full Text] [Related]
18. Myeloproliferative neoplasm with eosinophilia and PDGFR beta rearrangement in an infant.
Palla S; Boddu D; Matthew LG; Janet NB; Geevar T
Pediatr Blood Cancer; 2023 Jan; 70(1):e29856. PubMed ID: 35713205
[No Abstract] [Full Text] [Related]
19. Relapse of myeloid neoplasm with eosinophilia and PDGFRA rearrangement after imatinib discontinuation in a pediatric patient.
Rathe M; Schomerus E; Wehner PS; Kristensen TK; Møller MB
Pediatr Blood Cancer; 2014 Dec; 61(12):2328. PubMed ID: 25175494
[No Abstract] [Full Text] [Related]
20. [Myeloproliferative hypereosinophilic syndrome revealed by bipolar mucosal ulcerations].
Isvy-Joubert A; Hickman G; Flageul B; Battistella M; Bagot M; Galicier L; Petit A
Ann Dermatol Venereol; 2012 Oct; 139(10):636-40. PubMed ID: 23122377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]